Welcome to the e-CCO Library Archive!
M. Piqueras1, A. Jauregu2, M. Barreiro3, M. Iborra4, I. Bermell5, D. Carpio6, M. Chaparro7, A. Villoria8, T. Lobaton9, M. Calvo10, A. Fernandez11, S. Garcia-Moran12, D. Monfort1, R. Mena1, Y. Zabana13, 1Consorci Sanitari de Terrassa (CST), Gastroenterology department, Terrassa (Barcelona), Spain, 2Hospital Clinic Barcelona, Spain, 3Hospital Santiago de Compostela, Spain, 4Hospital la Fe de Valencia, Spain, 5Hospital Dr Negrin, Spain, 6Compejo Hospitalario de Pontevedra, Spain, 7Hospital La Princesa, Spain, 8Corporacio Sanitaria Parc Tauli, Spain, 9Hospital de Bellvitge, Spain, 10Hospital Puerta del Hierro, Spain, 11Hospital Povisa de Vigo, Spain, 12Hospital General Yagüe, Spain, 13H. Germans Trias I Pujol, Spain
Fecal calprotectin is correlated to Seo index in prediction of relapse in Iranian patients with Ulcerative Colitis
S.V. Hosseini1, P. Jafari2, S.A. Taghavi3, A. Rezaianzadeh4, M. Moini3, M. Mehrabi3, A.R. Safarpour*3
1Shiraz University of Medical Sciences, Colorectal Research Center, Shiraz, Iran, Islamic Republic of, 2Shiraz University of Medical Sciences, Biostatistics ward, Shiraz, Iran, Islamic Republic of, 3Shiraz University of Medical Sciences, Gastroenterohepatology Research Center, Shiraz, Iran, Islamic Republic of, 4Shiraz University of Medical Sciences, Nutrition and Health School, Shiraz, Iran, Islamic Republic of
Anemia in ulcerative colitis patients – a prospective monocentric study in North-Eastern Romania
G. Dumitrescu, C. Mihai, M. Dranga, O. Nedelciuc, C. Cijevschi Prelipcean, University of Medicine and Pharmacy “Gr. T. Popa”, Iasi, Institute of Gastroenterology and Hepatology, Iasi, Romania
N. Azzopardi1, P. Ellul1, 1Mater dei Hospital, Gastroenterology, Msida, Malta
Effectiviness of fecal calprotectin measurement determining deep remission in Inflammatory Bowel Disease
O. Sezgin*1, B. Boztepe2, E. Altintas3, E.A. Kanik4, D. Ovla4
1Mersin , Gastroenterology, Mersin, Turkey, 2Keşan State Hospital, Internal Medicine, Edirne, Turkey, 3Mersin, Gastroenterology, Mersin, Turkey, 4Mersin, Biostatistics and Bioinformatics, Mersin, Turkey
Agreement of central readers in the evaluation of histopathological disease activity in ulcerative colitis
M.H. Mosli1,2, B.G. Feagan2,3, G. Zou2,3, K. Geboes4, C. Langner5, M. Peterson6, R. Pai7, W.J. Sandborn2,8, G. D'Haens2,9, M.K. Vandervoort2, C. Behling10, K. Kaplan11, L.M. Shackelton2, J. Jones2, R. Khanna2, B.G. Levesque2,8, 1King Abdulaziz University, Department of Medicine, Jeddah, Saudi Arabia, 2Robarts Clinical Trials Inc., Robarts Research Institute, Western University, London, Ontario, Canada, 3Western University, Department of Epidemiology and Biostatistics, London Ontario, Canada, 4University Hospital of KU Leuven, Department of Pathology, Leuven, Belgium, 5Medical University of Graz, Institute of Pathology, Graz, Austria, 6Western Washington Pathology and Multicare Health System, Pathology, Tacoma, United States, 7Cleveland Clinic, Department of Anatomic Pathology, Cleveland Ohio, United States, 8University of California, San Diego, Division of Gastroenterology, La Jolla, United States, 9University of Amsterdam, Academic Medical Center, Amsterdam, Netherlands, 10Pacific Rim Pathology Medical Corporation, Pathology, San Diego California, United States, 11Carolinas Medical Center, Medicine, Charlotte North Carolina, United States
G. Hundorfean1, M.T. Chiriac1, M.F. Neurath1, J. Mudter1, 1University of Erlangen-Nuremberg, Medical Clinic 1 Erlangen, Erlangen, Germany
Surveillance for dysplasia in IBD: are we doing it right? Results from our daily practice
D. Trabulo*1, J. Moleiro2, I. Rosa2, C. Fidalgo3, J. Pereira da Silva2, P. Fidalgo4, R. Fonseca5, P. Chaves5, A. Dias Pereira2
1Centro Hospitalar de Setúbal - Hospital de São Bernardo, Gastroenterology, Setúbal, Portugal, 2Instituto Português de Oncologia de Lisboa Francisco Gentil, EPE, Gastroenterology, Lisboa, Portugal, 3Hospital Beatriz Ângelo, Gastroenterology, Loures, Portugal, 4Fundacao Champallimaud, Gastroenterology, Lisboa, Portugal, 5Instituto Português de Oncologia de Lisboa Francisco Gentil, EPE, Pathology, Lisboa, Portugal
Agreement among experts in the endoscopic evaluation of postoperative recurrence in Crohn's disease using the Rutgeerts score
K.B. Gecse1, M. Löwenberg1, P. Bossuyt2, P. Rutgeerts3, S. Vermeire4, L. Stitt5, M.K. Vandervoort5, W.J. Sandborn5,6, B.G. Feagan5,7, M.A. Samaan1,5, R. Khanna5, E. Dubcenco5, B.G. Levesque5,6, G. D'Haens1,5, 1University of Amsterdam, Academic Medical Center, Amsterdam, Netherlands, 2Imelda Hospital, Imelda GI Clinical Research Center, Bonheiden, Belgium, 3University Hospitals Gasthuisberg, Department of Gastroenterology, Leuven, Belgium, 4University Hospital, Department of Gastroenterology, Leuven, Belgium, 5Robarts Clinical Trials Inc., Robarts Research Institute, Western University, London, Ontario, Canada, 6University of California, San Diego, Division of Gastroenterology, La Jolla, United States, 7Western University, Department of Epidemiology and Biostatistics, Department of Medicine, London Ontario, Canada
L. de Ridder1, D. Turner2, S. Koletzko3, J. Martín de Carpi4, U.L. Fagerberg5, C. Spray6, M. Sladek7, D.C. Wilson8, E. Roma-Giannikou9, J. Bronsky10, D.E. Serban11, S. Cucchiara12, G. Veres13, F.M. Ruemmele14, I. Hojsak15, K.L. Kolho16, A. Levine17, 1Erasmus MC/Sophia Children's Hospital, Peadiatric Gastroenterology, Rotterdam, Netherlands, 2Shaare Zedek Medical Center, Jerusalem, Israel, 3University of Munich Medical Centre, Germany, 4Unidad para el Cuidado Integral de la Enfermedad Inflamatoria Intestinal Pediátrica, Sección de Gastroenterología, Hepatología y Nutrición Pediatrica, Hospital Sant Joan de Déu, Spain, 5Centre for Clinical Research, Västmanland County Hospital, Västerås, Karolinska Institutet, Sweden, 6Bristol Royal Hospital for Children, United Kingdom, 7Department of Pediatrics, Gastroenterology and Nutrition, Polish-American Children's Hospital, Jagiellonnian University Medical College, Poland, 8Child Life and Health, University of Edinburgh, United Kingdom, 91st Department of Paediatric of Athens University, Greece, 102nd Faculty of Medicine, Charles University and University Hospital Motol, Czech Republic, 11University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania, 12Pediatric Gastroenterology and Liver Unit, “La Sapienza” University, Italy, 13Semmelweis University, Hungary, 14Université Paris Descartes, Sorbonne Paris Cité, APHP, Hôpital Necker Enfants Malades, France, 15Referral Center for Pediatric Gastroenterology, Children's Hospital Zagreb, School of Medicine, University of Zagreb, Croatia, 16Children's Hospital, Helsinki, University Central Hospital and University of Helsinki, Finland, 17Wolfson Medical Center, Israel
A novel scoring system for differential diagnosis between Crohn's disease and intestinal tuberculosis: A prospective study
J.H. Bae*, S.H. Park, H.-S. Lee, H.J. Lee, J.S. Soh, S. Lee, M.S. Kwak, D.-H. Yang, K.-J. Kim, J.-S. Byeon, S.-J. Myung, S.-K. Yang, J.-H. Kim, B.D. Ye
University of Ulsan Collage of Medicine, Asan Medical Center, Gastroenterology, Seoul, Korea, Republic of
Age at diagnosis and clinical characteristics of Crohn's disease in Korea: a KASID multicenter study
S.W. Hwang1, J. Chun1, J.H. Lim1, J.P. Im1, J.H. Cheon2, B.D. Ye3, J.W. Kim4, Y.S. Kim5, J.S. Kim1, 1Seoul National University College of Medicine, Department of Internal Medicine and Liver Research Institute, Seoul, Korea, Republic of, 2Yonsei University College of Medicine, Internal Medicine, Seoul, Korea, Republic of, 3Ulsan University College of Medicine, Internal Medicine, Seoul, Korea, Republic of, 4Seoul National University Boramae Hospital, Seoul National University College of Medicine, Internal Medicine, Seoul, Korea, Republic of, 5Inje University College of Medicine, Internal Medicine, Seoul, Korea, Republic of